Psychiatry and Neurology, Neurology · Allentown, PA
NPI
1932416682
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1250 S Cedar Crest Blvd, Suite 405
Allentown, PA, 18103
Phone (610) 402-8420
Groups this clinician bills Medicare through
Medicare paid, 2024
$69K
2,095 services
Medicare patients, 2024
458
Average age 74
Drug cost, 2024
$2.1M
2,997 prescriptions
Company payments, 2025
$210K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Behrang Saminejad was code 99214 (office e&m - established), 225 times for 191 patients. In total Behrang Saminejad billed 2,095 services in 29 codes, and Medicare paid $69K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 225 | 191 | $65.60 | $15K |
| 95984 Electrical Nerve Conductivity | Facility | 222 | 35 | $31.97 | $7,096 |
| 95874 Musculoskeletal | Facility | 110 | 42 | $14.20 | $1,562 |
| 64616 Musculoskeletal | Facility | 105 | 37 | $115.48 | $12K |
| 95983 Electrical Nerve Conductivity | Facility | 71 | 35 | $36.44 | $2,587 |
| 99205 Office E&M - New | Facility | 60 | 60 | $113.25 | $6,795 |
| 99214 Office E&M - Established | Office | 56 | 50 | $64.62 | $3,619 |
| 99213 Office E&M - Established | Facility | 49 | 47 | $41.59 | $2,038 |
| 64642 Musculoskeletal | Facility | 29 | 13 | $71.11 | $2,062 |
| 64612 Musculoskeletal | Facility | 26 | 11 | $97.16 | $2,526 |
| 99215 Office E&M - Established | Facility | 24 | 23 | $100.44 | $2,411 |
| 95970 Electrical Nerve Conductivity | Facility | 23 | 18 | $12.54 | $288 |
| 99204 Office E&M - New | Facility | 21 | 21 | $87.84 | $1,845 |
| 99222 Hospital E&M - Initial | Facility | 17 | 17 | $95.27 | $1,620 |
| 99205 Office E&M - New | Office | 14 | 14 | $75.83 | $1,062 |
By year: 2022 $79K for 1,678 services; 2023 $71K for 2,810 services; 2024 $69K for 2,095 services.
Medicare prescription drug claims, 2024
In 2024, the drug Behrang Saminejad prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 814 prescriptions and refills. In total Behrang Saminejad wrote 2,997 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 814 | 2,084 | 247 | $43K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 201 | 483 | 70 | $12K |
| Primidone Generic | 188 | 469 | 58 | $7,440 |
| Amantadine Amantadine Hcl | 145 | 380 | 50 | $5,635 |
| Clonazepam Generic | 137 | 186 | 36 | $1,217 |
| Propranolol Hcl Generic | 127 | 327 | 52 | $3,676 |
| Gabapentin Generic | 107 | 241 | 31 | $2,506 |
| Austedo Xr Deutetrabenazine | 96 | 112 | Under 11 | $690K |
| Rasagiline Mesylate Generic | 82 | 236 | 26 | $16K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 75 | 188 | 26 | $4,712 |
| Ropinirole Hcl Generic | 65 | 156 | 15 | $1,557 |
| Rivastigmine Generic | 58 | 84 | 14 | $8,205 |
| Ingrezza Valbenazine Tosylate | 55 | 55 | Under 11 | $337K |
| Rytary Carbidopa/Levodopa | 55 | 81 | Under 11 | $66K |
| Propranolol Hcl Er Propranolol Hcl | 48 | 115 | 16 | $1,974 |
Brand drugs: 431 claims; generic drugs: 2,566 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Behrang Saminejad $210K ($210K in general payments such as food, travel and fees) from 10 companies. The largest payer was Neurocrine BioSciences, Inc. with $103K.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 95 | $103K |
| Teva Pharmaceuticals USA, Inc. TEVA | 71 | $76K |
| MDD US Operations, LLC | 39 | $28K |
| Medtronic, Inc. MDT | 28 | $3,141 |
| Abbott Laboratories ABT | 3 | $289 |
| Abbvie Inc. ABBV | 4 | $120 |
| Revance Therapeutics, Inc. | 3 | $89.19 |
| SpringWorks Therapeutics, Inc. | 3 | $54.8 |
| Supernus Pharmaceuticals, Inc. SUPN | 5 | $52.98 |
| ACADIA Pharmaceuticals Inc ACAD | 1 | $13.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.